Navigation Links
Cryo-Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics, Inc.
Date:1/29/2008

O 9001:2000 certified and accredited by the AABB, Cryo-Cell operates in a state-of-the-art Good Manufacturing Practice and Good Tissue Practice (cGMP/cGTP)-compliant facility. Cryo-Cell is a publicly traded company. OTC Bulletin Board Symbol: CCEL. For more information, please call 1-800-STOR-CELL (1-800-786-7235) or visit http://www.cryo-cell.com. For more information about C'elle visit http://www.celle.com.

Forward-Looking Statement

Statements wherein the terms "believes", "intends", "projects" or "expects" as used are intended to reflect "forward-looking statements" of the Company. The information contained herein is subject to various risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated in such forward-looking statements or paragraphs, many of which are outside the control of the Company. These uncertainties and other factors include the uncertainty of market acceptance of any potential service offerings relating to types of stem cells other than cord blood stem cells, including the C'elle service, given that menstrual stem cells and other new stem cells have not yet been used in human therapies, and treatment applications using such stem cells are not likely to be developed and commercialized for many years and are subject to further research and development; the need for additional development and testing before determining the ultimate commercial value of the Company's intellectual property relating to the menstrual stem cells; the need to complete certain developments, including completion of clinical validation and testing, before any new process other than C'elle can be commercialized, and the Company's development of its final business and economic model in offering any such service; any adverse effect or limitations caused by recent increases in government regulation of ste
'/>"/>

SOURCE Cryo-Cell International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Access Pharmaceuticals Announces $2.7 Million New Equity
2. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
3. Oncolytics Biotech Inc. Announces Issuance of 8th Canadian Patent
4. ARIUS announces fourth quarter and year-end fiscal 2007 financial results
5. China Bionanometer Industries Corporation Announces Record Second Quarter 2007 Results
6. 3SBio Inc. Announces Appointment of Kevin Sow Peng Teo as Chief Financial Officer
7. Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award
8. Arbor Surgical Technologies Announces Series C Financing and Licensing Agreement with Medtronic
9. Hoya Announces Third Quarter and Nine Month Results for 2007
10. Medefield Announces New Appointments to North American Business Unit
11. NuVasive Announces Webcast and Conference Call of Fourth Quarter and Full Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... SoundConnect , a unified communication ... of the nation’s Fastest Growing Private Companies by ... consecutive year. Inc. magazine today ranked SoundConnect NO. ... exclusive ranking of the nation's fastest-growing private companies. ... the most important segment of the economy—America’s independent ...
(Date:8/20/2014)... analysis of patented university inventions licensed to biotechnology ... to commercialization. To open these roadblocks, the researchers ... during the discovery stage could lead to faster ... frequently derived from discoveries made in university laboratories ... known during clinical trials, which have a high ...
(Date:8/20/2014)... Aug. 20, 2014 Neurotrope, Inc. (OTCQB: ... conference call to provide an update on Company ... daylight timeDial-in numbers:(888) 505-4369 (U.S. and Canada) or ... cast: www.neurotropebioscience.com , under "Investor Relations"The teleconference replay ... through September 2, 2014 at (888) 203-1112 (U.S. ...
(Date:8/20/2014)... , Aug. 20, 2014  PAREXEL International Corporation (NASDAQ: ... be presenting at the Baird Healthcare Conference in New ... Chief Financial Officer, will be making a presentation on ... on Wednesday, Sept. 3, 2014. A live ... "Investors" section of PAREXEL,s website at www.PAREXEL.com ...
Breaking Biology Technology:SoundConnect Returns on Inc. 5000 List of Fastest Growing Companies 2SoundConnect Returns on Inc. 5000 List of Fastest Growing Companies 3Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3Neurotrope To Host Conference Call 2PAREXEL International To Present At Baird Healthcare Conference 2
... thin layers of graphite known as graphene ... potential electronic devices. Researchers have now experimentally demonstrated ... interconnects in future generations of integrated circuits. In ... the IEEE journal Electron Device Letters , researchers ...
... For the second time in three years, the Best of State ... as Utah,s top, company in the Medical Innovation ... - American Biotech Labs, LLC (ABL), developer of a new class ... announced that the company has won the 2009 Utah Best of ...
... SEATTLE, June 5 Dendreon Corporation (Nasdaq: DNDN ) today ... week. , , Goldman Sachs 30th Annual Global Healthcare ... p.m. ET, 8th Annual Needham Life Sciences Conference, ... , The presentations will be audio webcast live and available ...
Cached Biology Technology:Graphene may have advantages over copper for IC interconnects at the nanoscale 2Graphene may have advantages over copper for IC interconnects at the nanoscale 3American Biotech Labs(R) Garners 2009 Utah Best of State Award 2American Biotech Labs(R) Garners 2009 Utah Best of State Award 3
(Date:8/20/2014)... research finds life can persist in a cold, dark ... a team that examined waters and sediments from a ... found the extreme environment supports microbial ecosystems. , ... her colleagues has implications for life in other extreme ... The findings are published in the current edition of ...
(Date:8/20/2014)... Calif., August 19, 2014 -- Bay Area Lyme Foundation, ... and simple to cure, applauds new research published in ... Ticks and Tick-borne Diseases . The findings ... California are active throughout the year, making the threat ... researchers at California Department of Public Health (CDPH) Vector-borne ...
(Date:8/20/2014)... causes a burning spiciness that is irresistible to some, ... effect are using their findings to develop a new ... be caused by inflammation or other problems. They reported ... in clinical trials, in ACS, Journal of Medicinal ... decades ago, scientists had pegged a compound called capsaicin ...
Breaking Biology News(10 mins):University of Tennessee research uncovers subglacial life beneath Antarctic ice sheet 2Lyme disease risk is year-round in Northwest California, according to new study 2Lyme disease risk is year-round in Northwest California, according to new study 3
... the mid 19th century, a French doctor, Armand Trousseau, discovered ... often dangerous blood clots that can lead to venous occlusion. ... blood flow properties and thus promote the formation of clots. ... and consequence of cancer, but, vice versa, an increased blood ...
... COLUMBIA, Mo. A new University of Missouri study ... (BPA) through diet has been underestimated by previous lab tests. ... were given a steady diet supplemented with BPA throughout the ... exposure, and found an increased absorption and accumulation of BPA ...
... Outbreak Strain Reported By ... Germany In 2001 Stocks And Samples Of ... Not Previously Sequenced Following ... ), BGI, based in Shenzhen, China, and its ...
Cached Biology News:Blood clotting and bowel cancer risk 2Exposure to BPA has been underestimated, new MU research says 2BGI and Collaborators Announce New Clues Found in Tracing the Origin of the Deadly E. coli Strain and Appeal for the Sharing of Additional Data 2BGI and Collaborators Announce New Clues Found in Tracing the Origin of the Deadly E. coli Strain and Appeal for the Sharing of Additional Data 3BGI and Collaborators Announce New Clues Found in Tracing the Origin of the Deadly E. coli Strain and Appeal for the Sharing of Additional Data 4
... Mouse monoclonal [APS 26] to Presenilin ... an inherited form of the disease carry ... or the amyloid precursor protein (APP). These ... the longer form of amyloid-beta (main component ...
One-step, microplate or cuvet, colorimetric, linear detection range 6 mg/dL to 100mg/dL. Procedure: 15 min....
[5,6,8,9,12,14,15(n)-3H]Prostaglandin D2, 925 kBq, 25 uCi. Methanol:water:acetonitrile (3:2:1) solution.> 3.0 TBq/mmol, > 80 Ci/mmol.3.7 MBq/ml, 100 uCi/ml. Category: Radiochemicals &Radiation Safety...
... with Purpose -- The Varian ... the highest level of flexibility ... an affordable, easy-to-use system. The ... workstation guarantees success with today's ...
Biology Products: